Drug
Who makes lusutrombopag?
3 companies list lusutrombopag as a human prescription drug, including under the names Mulpleta. Forms: tablet, film coated. Routes: oral.
Labellers from the openFDA NDC Directory. A labeller is the firm named on the label, not necessarily the site that made the product, and a listing is not an FDA approval. Data as of 24 Sept 2026. Methodology
Companies listing lusutrombopag
| Company | Forms | Application | NDCs | Registered sites |
|---|---|---|---|---|
| Shionogi Pharma Co., Ltd.Japan | tablet, film coated | NDANDA210923 | 1 | 4 |
| Eddingpharm (U. S. ) Inc. | tablet, film coated | NDANDA210923 | 1 | 0 |
| VANCOCIN ITALIA SRL | tablet, film coated | NDANDA210923 | 1 | 0 |
Bulk ingredient listings
- Shionogi Pharma Co., Ltd.Japan · 1 NDC
Orange Book patents
3 unexpired patents list lusutrombopag as the active ingredient, expiring between Jul 2028 and Sept 2031. Application holder: VANCOCIN ITALIA SRL.
Enquiry
Common questions
- Who makes lusutrombopag?
- 3 companies list lusutrombopag as a human prescription drug in the openFDA NDC Directory, led by Shionogi Pharma Co., Ltd., Eddingpharm (U. S. ) Inc., VANCOCIN ITALIA SRL. Each is the labeller, the firm named on the label; the product may be made at a site registered to another company.
- Who supplies lusutrombopag active ingredient?
- 1 company lists lusutrombopag as a bulk ingredient, including Shionogi Pharma Co., Ltd..